Skip to main content

Market Overview

Why Precision BioSciences' Stock Is Trading Higher Today

Why Precision BioSciences' Stock Is Trading Higher Today

Precision BioSciences (NASDAQ: DTIL) shares are trading higher on Wednesday after the company announced it received fast track designation from the FDA for its PBCAR269A investigational allogeneic CAR T therapy for relapsed and refractory Multiple Myeloma.

Precision BioSciences is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

Precision BioSciences shares were trading up 2.63% at $5.47 at the time of publication Wednesday. The stock has a 52-week high of $23.67 and a 52-week low of $4.46.


Related Articles (DTIL)

View Comments and Join the Discussion!

Posted-In: why it's movingNews

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at